Urinary cytokines as potential biomarkers of mild cognitive impairment and Alzheimer’s disease: a pilot study

Files

Authors

Nazia Saiyed, Beaumont Health
Ali Yilmaz, Beaumont Health
Sangeetha Vishweswariah, Beaumont Health
Sarah Bartolone, Beaumont Health
Tammy Osentoski, Beaumont Health
Stacey Ruff, Beaumont Health
Amita Pai, Beaumont Health
Michael Maddens, Beaumont Health
Khaled Imam, Beaumont Health
Stewart F. Graham, Beaumont Health

Publication Date

10-21-2022

Keywords

Alzheimer's disease, dementia, mild cognitive impairment, aging

Disciplines

Endocrinology, Diabetes, and Metabolism | Geriatrics | Internal Medicine | Laboratory and Basic Science Research | Urology

Recommended Citation

Saiyed N, Yilmaz A, Vishweswaraiah S, Maiti AK, Ustun I, Bartolone S et al [Imam K, Maddens M, Osentoski T, Ruff S, Pai A, Graham S]. Urinary cytokines as potential biomarkers of mild cognitive impairment and Alzheimer’s disease: a pilot study. The BHSH Research Summit; 2022 Oct 21; Grand Rapids, MI.

Comments

The BHSH Research Summit, Spectrum Health, Grand Rapids, MI, October 21, 2022.